University of Copenhagen
Copenhagen, 2200, Denmark
NCT Number: NCT05356845
Introduction: Problems with oral health (dental and oral diseases) as well as orofacial function (jaw opening, chewing and salivation problems) are significant challenges for many people with Parkinson's disease (PD). These challenges may be painful, disabling, and cause great psychosocial strain and negatively affect quality of life. Furthermore, they may contribute to an unsecure and unhealthy aging, because eating and enjoyment of food is important for both the physical and psychological wellbeing for elderly and chronically ill patients. It seems that patients with PD often find it difficult to maintain adequate oral hygiene and fail to visit the dentist, which in the end contributes to tooth loss, eating problems, poorer nutrition, social challenges and reduced quality of life.
To be able to plan interventions on a larger scale more detailed knowledge and mapping is necessary on the extent of various manifestations of PD in the orofacial area, the affect on the patients and their quality of life, and how the disease develops in the orofacial area for the patient group over time. The study will clarify the challenges and problems that patients with PD have due to their disease in terms of dental and oral health and function of mouth and jaws. Such information is important both for single patients with respect to prevention and intervention and for development of community health strategies.
Purpose
* to investigate specific orofacial, non-motor and motor symptoms and functions as well as the oral microbiome in patients with PD compared to a control group. * to examine the quality of life related to oral health in the abovementioned groups. * to provide information on the orofacial problems in PD for the benefit of single patients with respect to prevention and intervention and for development of community health strategies.
Hypotheses: It is expected that
* patients with PD have more orofacial functional problems and poorer oral health than a control group without PD, and patients with late PD have more orofacial functional problems and poorer oral health than patients with early PD. * patients with PD have an altered oral microbiome compared to a control group without PD, which possibly may assist in the staging of PD. * patients with PD have poorer oral health related quality of life and home dental care than a control group without PD.
Looking for future studies?
Notify Me18 year–100 year
All sexes
Observational
Copenhagen, 2200, Denmark
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Basline
Measurment: micro volt. Electromyographic measurement of the resting, chewing, swallowing, jaw opening and teeth clenching of the temporalis muscle, the digastric muscle and the masseter bilaterally. Detected with bipolar surface electrodes during 10 s resting and posture activity, chewing 10 g apple, swallowing 2 mL water, maximal jaw opening and teeth clenching.
Time frame: basline
Measure the maximum molar bite force using a transducer in Newton
Time frame: baseline
Oral Health Impact Profile questionnaire with 14 questions regarding disability, pain, discomfort, physical impairment, mental impairment, social impairment and disability. Scale from 0-56
Time frame: Basline
Measurment: DMFT. Obtained by dental examination and Panoramic radiograph
Time frame: Basline
Meaure of The orofacial function on a scale from 0 to 12
University of Copenhagen
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05608915
Basal Ganglia Diseases, Brain Diseases
Cleveland, Ohio, United States
View Trial DetailsNCT04925622
Autonomic Nervous System Diseases, Basal Ganglia Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT03065192
Basal Ganglia Disease, Basal Ganglia Diseases
San Francisco, California, United States
View Trial DetailsNCT04704349
Basal Ganglia Diseases, Brain Diseases
Orléans, France
View Trial Details